Pulmonary expression of ACE-2 (the major receptor for SARS-CoV-2), immunocompromised state, obesity, pre-existing endothelial dysfunction, and the tendency to hypercoagulability are all features that render diabetic patients more vulnerable to SARS-CoV-2 [29,30]. This evidence concerns the gene ACE2 and thrombophilia.